Also known as: TA1
Molecular Weight
3108 Da
Half-Life
2 hours
Administration
Subcutaneous injection
Longevity Score
8/10
A 28-amino acid immunomodulating polypeptide that stimulates both innate and adaptive immune responses. Activates Toll-like receptors and downstream signaling pathways. Restores immune homeostasis and enhances T-cell function, dendritic cell maturation, and cytokine production.
beginner
0.8mg 2x/week
intermediate
1.0mg 3x/week
advanced
1.5mg 3x/week
athlete
1.5mg 3x/week
Frequency: 3x weekly · Duration: 8–12 weeks per cycle, with 4-week breaks between cycles
Week 1-2
Improved energy, reduced minor illness duration
Week 3-4
Notable immune resilience, better recovery
Week 5-8
Significant immune optimization, enhanced CD8+ T-cell response
Long Term
Sustained immune function improvement
Contraindications:
Thymosin alpha-1 in hepatitis B treatment (2008)
Demonstrated antiviral efficacy in chronic hepatitis B patients
DOI: 10.1016/j.jhep.2008.03.023Explore more peptides in this category
View All Immune Peptides →Research Disclaimer: This information is compiled from published research and is provided for educational purposes only. Peptides discussed here are classified as research chemicals in most jurisdictions and are not FDA-approved for human use unless otherwise noted. Consult a qualified healthcare provider before starting any protocol.